Kaori Tsuyuki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kaori Tsuyuki has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Miho Egawa
Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan
3 shared publications - Takuma Ohsuga
Kyoto University Graduate School of Medicine
3 shared publications Atsuko Kawamura
Shizuoka General Hospital
2 shared publicationsJunichi Aratake
Shizuoka General Hospital
2 shared publications- Masaki Mandai
Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan
2 shared publications Megumi Yamanishi
Shizuoka General Hospital
2 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Effectiveness of a Personalized Self-Care Smartphone Application for Menopausal Symptoms in Midlife Women: Randomized Controlled Trial (Preprint)
BACKGROUND Menopausal symptoms can substantially affect the health and daily lives of midlife women, yet many women do not seek or receive adequate support. Smartphone-based interventions may provide an accessible approach to supporting women with menopausal symptoms, but randomized evidence for personalized, self-directed interventions remains limited. OBJECTIVE This study aimed to evaluate the effectiveness of JoyHer Pro, a personalized self-care smartphone application, in reducing menopausal symptoms among midlife women. METHODS We conducted a fully remote, 12-week, two-arm, parallel-group randomized controlled trial in Japan. Women aged 45 to <60 years with irregular or absent menstruation and a Menopause Rating Scale (MRS) total score of ≥5 were recruited online and randomly assigned 1:1 to the intervention or control group using permuted-block randomization stratified by screening MRS score (<9 vs ≥9). Both groups received access to the same 58 educational topics, with the recommended content order personalized according to symptoms selected at registration. The intervention group additionally had access to daily self-monitoring, algorithmically personalized self-care advice (“Tips”) updated every 2 weeks without individualized input from clinicians or researchers, and daily notifications. The primary outcome was the self-reported MRS total score at week 12, analyzed using a mixed model for repeated measures. The prespecified full analysis set comprised randomized participants who downloaded the assigned application and completed the baseline questionnaire. RESULTS Of 584 randomized participants, 401 were included in the full analysis set (intervention, n=197; control, n=204). At week 12, the adjusted mean MRS total score was 10.29 (95% CI 9.64-10.95) in the intervention group and 11.98 (95% CI 11.34-12.61) in the control group, with an adjusted between-group difference of −1.68 points (95% CI −2.59 to −0.77; P<.001). Differences favoring the intervention were also observed at weeks 4 and 8. Exploratory analyses showed lower somatic, psychological, and urogenital MRS subscale scores in the intervention group at week 12. In a post hoc responder analysis, 42.1% (72/171) of participants in the intervention group and 26.9% (49/182) in the control group achieved a ≥5-point reduction in MRS total score at week 12 (risk difference 15.2 percentage points; relative risk 1.56). The median number of application login days was 16 in the intervention group and 5 in the control group. No intervention-related adverse events were spontaneously reported. CONCLUSIONS In this randomized controlled trial, a 12-week personalized self-care smartphone intervention produced a greater reduction in menopausal symptoms than a limited-function educational control application providing the same educational content with baseline symptom-based personalization. These findings support the potential of a fully self-directed smartphone intervention integrating longitudinal symptom self-monitoring with self-care support repeatedly personalized based on accumulated user data to help women manage menopausal symptoms in daily life. CLINICALTRIAL UMIN Clinical Trials Registry: UMIN000060039; https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000067727
- 11 November 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEffectiveness of a Personalized Self-Care Smartphone Application for Menopausal Symptoms in Midlife Women: Randomized Controlled Trial (Preprint)
BACKGROUND Menopausal symptoms can substantially affect the health and daily lives of midlife women, yet many women do not seek or receive adequate support. Smartphone-based interventions may provide an accessible approach to supporting women with menopausal symptoms, but randomized evidence for personalized, self-directed interventions remains limited. OBJECTIVE This study aimed to evaluate the effectiveness of JoyHer Pro, a personalized self-care smartphone application, in reducing menopausal symptoms among midlife women. METHODS We conducted a fully remote, 12-week, two-arm, parallel-group randomized controlled trial in Japan. Women aged 45 to <60 years with irregular or absent menstruation and a Menopause Rating Scale (MRS) total score of ≥5 were recruited online and randomly assigned 1:1 to the intervention or control group using permuted-block randomization stratified by screening MRS score (<9 vs ≥9). Both groups received access to the same 58 educational topics, with the recommended content order personalized according to symptoms selected at registration. The intervention group additionally had access to daily self-monitoring, algorithmically personalized self-care advice (“Tips”) updated every 2 weeks without individualized input from clinicians or researchers, and daily notifications. The primary outcome was the self-reported MRS total score at week 12, analyzed using a mixed model for repeated measures. The prespecified full analysis set comprised randomized participants who downloaded the assigned application and completed the baseline questionnaire. RESULTS Of 584 randomized participants, 401 were included in the full analysis set (intervention, n=197; control, n=204). At week 12, the adjusted mean MRS total score was 10.29 (95% CI 9.64-10.95) in the intervention group and 11.98 (95% CI 11.34-12.61) in the control group, with an adjusted between-group difference of −1.68 points (95% CI −2.59 to −0.77; P<.001). Differences favoring the intervention were also observed at weeks 4 and 8. Exploratory analyses showed lower somatic, psychological, and urogenital MRS subscale scores in the intervention group at week 12. In a post hoc responder analysis, 42.1% (72/171) of participants in the intervention group and 26.9% (49/182) in the control group achieved a ≥5-point reduction in MRS total score at week 12 (risk difference 15.2 percentage points; relative risk 1.56). The median number of application login days was 16 in the intervention group and 5 in the control group. No intervention-related adverse events were spontaneously reported. CONCLUSIONS In this randomized controlled trial, a 12-week personalized self-care smartphone intervention produced a greater reduction in menopausal symptoms than a limited-function educational control application providing the same educational content with baseline symptom-based personalization. These findings support the potential of a fully self-directed smartphone intervention integrating longitudinal symptom self-monitoring with self-care support repeatedly personalized based on accumulated user data to help women manage menopausal symptoms in daily life. CLINICALTRIAL UMIN Clinical Trials Registry: UMIN000060039; https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000067727
- Open Access
- 20 May 2026
- Published by Springer Nature in BMC Women's Health
- Vol. 26 (1)
A digital self-care intervention for psychological distress associated with premenstrual syndrome: a fully online controlled trial using alternating allocation
Background: Premenstrual syndrome (PMS) is associated with significant psychological distress and productivity loss in women. This study aimed to evaluate whether a low-intensity digital intervention—comprising a symptom-tracking smartphone application and standardized informational emails—could reduce the psychological burden of PMS among women who self-identified as experiencing PMS. Methods: We conducted a fully internet-based, open-label, parallel-group, nonrandomized controlled trial using centrally administered alternating allocation among women aged 18 years or older in Japan who self-identified as experiencing PMS. Participants were allocated alternately to either a 3-month intervention group (daily symptom tracking using a smartphone app and twice-weekly informational emails) or a waitlist control group. The primary outcome was the between-group difference in change scores on the psychological subscale of the Japanese version of the PMS-Impact Scale, measured from baseline to 3 months. Analyses were conducted per protocol. Results: A total of 419 women were enrolled and assigned to either the intervention group (n = 210) or the waitlist control group ( n = 209). Of these, 355 participants were included in the per-protocol analysis. The intervention group showed greater improvement in self-reported psychological distress than the waitlist control group. The between-group difference in change score, defined as intervention minus control, was − 1.37 points (95% CI, − 2.47 to − 0.27; p = 0.015). Conclusions: A simple, scalable digital intervention was associated with greater improvement in self-reported psychological distress among women who self-identified as experiencing PMS. These findings suggest that accessible, non–clinician-led tools may have potential as a self-management strategy for PMS, although causal interpretation is limited by the nonrandomized design. Trial registration: This trial was registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR) on September 26, 2022. Trial registration number: UMIN000048422.
- 20 May 2026
- Published by Springer Nature in BMC Women's Health
- Vol. 26 (1)
Open AccessA digital self-care intervention for psychological distress associated with premenstrual syndrome: a fully online controlled trial using alternating allocation
Background: Premenstrual syndrome (PMS) is associated with significant psychological distress and productivity loss in women. This study aimed to evaluate whether a low-intensity digital intervention—comprising a symptom-tracking smartphone application and standardized informational emails—could reduce the psychological burden of PMS among women who self-identified as experiencing PMS. Methods: We conducted a fully internet-based, open-label, parallel-group, nonrandomized controlled trial using centrally administered alternating allocation among women aged 18 years or older in Japan who self-identified as experiencing PMS. Participants were allocated alternately to either a 3-month intervention group (daily symptom tracking using a smartphone app and twice-weekly informational emails) or a waitlist control group. The primary outcome was the between-group difference in change scores on the psychological subscale of the Japanese version of the PMS-Impact Scale, measured from baseline to 3 months. Analyses were conducted per protocol. Results: A total of 419 women were enrolled and assigned to either the intervention group (n = 210) or the waitlist control group ( n = 209). Of these, 355 participants were included in the per-protocol analysis. The intervention group showed greater improvement in self-reported psychological distress than the waitlist control group. The between-group difference in change score, defined as intervention minus control, was − 1.37 points (95% CI, − 2.47 to − 0.27; p = 0.015). Conclusions: A simple, scalable digital intervention was associated with greater improvement in self-reported psychological distress among women who self-identified as experiencing PMS. These findings suggest that accessible, non–clinician-led tools may have potential as a self-management strategy for PMS, although causal interpretation is limited by the nonrandomized design. Trial registration: This trial was registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR) on September 26, 2022. Trial registration number: UMIN000048422.
- Open Access
- 27 March 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e88430
An Empirical Approach to Curriculum Mapping in Traditional Kampo Medicine Education in Japan: Practical Methodological Study
Background: The integration of traditional and complementary medicine (T&CM) into modern medical education remains a global challenge. Kampo medicine, a Japanese traditional pharmacotherapy, is recognized in the International Classification of Diseases, 11th Revision , and is widely used; however, no structured methodology exists for efficiently designing curricula within limited time and resources. To address this gap, this study proposes a methodological framework—illustrated through Kampo medicine but generalizable to other forms of T&CM—for organizing and visualizing curricular content to guide educational needs assessment and curriculum design. Objective: The objective of this study was to develop and illustrate a reproducible mapping framework that integrates (1) real-world clinical utilization frequency and (2) the accumulation of biomedical evidence to inform educational prioritization and stepwise curriculum design for T&CM, using Kampo medicine as an exemplar. Methods: A mapping approach was developed based on two perspectives: frequency of use in clinical training and level of biomedical evidence. Twelve years of outpatient prescription data from Kyoto University Hospital were analyzed to identify the most frequently prescribed Kampo formulas. For the 10 most common formulas, PubMed searches were conducted to determine the number of randomized controlled trials. Data were integrated using hierarchical clustering and plotted along frequency–evidence axes to produce an educational priority map, which informed a stepwise curriculum design grounded in adult learning theory. Results: Prescription heat maps revealed substantial interdepartmental variation, and clustering identified distinct groups of formulas based on usage patterns. No statistically significant correlation was observed between prescription frequency and level of evidence (Pearson r =0.228, 95% CI −0.469 to 0.750; P =.53; Spearman ρ=0.498, 95% CI −0.308 to 0.926; P =.14). Integrating these two perspectives enabled interpretation of real-world prescription patterns and supported a transparent educational prioritization framework. Conclusions: This study presents a feasible and adaptable framework that links real-world clinical data with biomedical evidence to inform curriculum design in T&CM. Rather than prescribing specific content, the framework offers visual decision-making tools that align educational priorities with institutional practice patterns and can be readily adapted to complementary, alternative, and integrative medicine programs internationally.
- 27 March 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e88430
Open AccessAn Empirical Approach to Curriculum Mapping in Traditional Kampo Medicine Education in Japan: Practical Methodological Study
Background: The integration of traditional and complementary medicine (T&CM) into modern medical education remains a global challenge. Kampo medicine, a Japanese traditional pharmacotherapy, is recognized in the International Classification of Diseases, 11th Revision , and is widely used; however, no structured methodology exists for efficiently designing curricula within limited time and resources. To address this gap, this study proposes a methodological framework—illustrated through Kampo medicine but generalizable to other forms of T&CM—for organizing and visualizing curricular content to guide educational needs assessment and curriculum design. Objective: The objective of this study was to develop and illustrate a reproducible mapping framework that integrates (1) real-world clinical utilization frequency and (2) the accumulation of biomedical evidence to inform educational prioritization and stepwise curriculum design for T&CM, using Kampo medicine as an exemplar. Methods: A mapping approach was developed based on two perspectives: frequency of use in clinical training and level of biomedical evidence. Twelve years of outpatient prescription data from Kyoto University Hospital were analyzed to identify the most frequently prescribed Kampo formulas. For the 10 most common formulas, PubMed searches were conducted to determine the number of randomized controlled trials. Data were integrated using hierarchical clustering and plotted along frequency–evidence axes to produce an educational priority map, which informed a stepwise curriculum design grounded in adult learning theory. Results: Prescription heat maps revealed substantial interdepartmental variation, and clustering identified distinct groups of formulas based on usage patterns. No statistically significant correlation was observed between prescription frequency and level of evidence (Pearson r =0.228, 95% CI −0.469 to 0.750; P =.53; Spearman ρ=0.498, 95% CI −0.308 to 0.926; P =.14). Integrating these two perspectives enabled interpretation of real-world prescription patterns and supported a transparent educational prioritization framework. Conclusions: This study presents a feasible and adaptable framework that links real-world clinical data with biomedical evidence to inform curriculum design in T&CM. Rather than prescribing specific content, the framework offers visual decision-making tools that align educational priorities with institutional practice patterns and can be readily adapted to complementary, alternative, and integrative medicine programs internationally.
- Open Access
- 1 January 2024
- Published by Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy in JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY
- Vol. 40 (1) , 146-149
A case of noncommunicating rudimentary uterine horn with dysmenorrheal symptoms after cesarean section
A unicornuate uterus with a rudimentary horn is an uncommon anomaly that affects 0.1% of all women. Here, we present the case of a 29-year-old woman who underwent laparoscopic surgery for a rudimentary uterine horn. At 28 years of age, she became pregnant with her first child. The pregnancy resulted in intrauterine fetal death at 23 weeks of gestation.Initially, a uterine malformation was not diagnosed, but no apparent connection was observed between the uterus and vagina, leading to a suspicion of noncommunicating rudimentary horn pregnancy. She underwent a cesarean section because vaginal delivery was deemed impossible. Postoperatively, the dysmenorrhea worsened. Magnetic resonance imaging (MRI) revealed a cesarean scar defect and a retained hematoma in the fallopian tube. She was referred to our hospital six months after her cesarean section. Laparoscopic resection of the rudimentary horn was performed to ease her symptoms and increase her chances of future pregnancy. No apparent connections were observed between the contralateral horns. Her dysmenorrhea subsided after the laparoscopic surgery. An MRI performed two months after surgery revealed no rudimentary horn resection scar defects. She conceived spontaneously 16 months after the laparoscopic surgery and delivered via cesarean section. When a cesarean section is performed for a rudimentary horn pregnancy, early removal of the rudimentary horn is desirable to prevent recurrence. During the waiting period or when the rudimentary horn is preserved, postoperative dysmenorrhea may occur. The evaluation of surgical scarring using MRI after rudimentary horn resection is useful for managing patients who wish to conceive.
- 1 January 2024
- Published by Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy in JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY
- Vol. 40 (1) , 146-149
Open AccessA case of noncommunicating rudimentary uterine horn with dysmenorrheal symptoms after cesarean section
A unicornuate uterus with a rudimentary horn is an uncommon anomaly that affects 0.1% of all women. Here, we present the case of a 29-year-old woman who underwent laparoscopic surgery for a rudimentary uterine horn. At 28 years of age, she became pregnant with her first child. The pregnancy resulted in intrauterine fetal death at 23 weeks of gestation.Initially, a uterine malformation was not diagnosed, but no apparent connection was observed between the uterus and vagina, leading to a suspicion of noncommunicating rudimentary horn pregnancy. She underwent a cesarean section because vaginal delivery was deemed impossible. Postoperatively, the dysmenorrhea worsened. Magnetic resonance imaging (MRI) revealed a cesarean scar defect and a retained hematoma in the fallopian tube. She was referred to our hospital six months after her cesarean section. Laparoscopic resection of the rudimentary horn was performed to ease her symptoms and increase her chances of future pregnancy. No apparent connections were observed between the contralateral horns. Her dysmenorrhea subsided after the laparoscopic surgery. An MRI performed two months after surgery revealed no rudimentary horn resection scar defects. She conceived spontaneously 16 months after the laparoscopic surgery and delivered via cesarean section. When a cesarean section is performed for a rudimentary horn pregnancy, early removal of the rudimentary horn is desirable to prevent recurrence. During the waiting period or when the rudimentary horn is preserved, postoperative dysmenorrhea may occur. The evaluation of surgical scarring using MRI after rudimentary horn resection is useful for managing patients who wish to conceive.
- Open Access
- 13 December 2022
- Published by Hindawi Limited in Case Reports in Obstetrics and Gynecology
- Vol. 2022, 1-4
A Case of Uterine Lymphangioleiomyomatosis Complicated by Tuberous Sclerosis Complex
Lymphangioleiomyomatosis (LAM) is one of the presentations of perivascular epithelioid cell neoplasm that is frequently complicated by tuberous sclerosis complex (TSC). Here, we report an uncommon case of uterine LAM treated with everolimus, which is a mechanistic target of rapamycin (mTOR) inhibitor. A 42-year-old female patient (gravida 0) with a history of TSC presented with abdominal pain. Pelvic magnetic resonance imaging showed multiple masses in the uterine myometrium, suggesting tumors that may contain internal hemorrhagic components. The lesions were suspected as the root cause of her symptoms. After everolimus was administered for a previously diagnosed renal angiolipoma, her uterine tumors temporarily decreased in size. Subsequently, laparoscopic hysterectomy and bilateral salpingectomy were performed since she could not tolerate everolimus for a long period due to the medications side effects. Furthermore, the patient was diagnosed with LAM through histopathological examination after surgical resection. Therefore, it is advisable to suspect and investigate uterine LAM when a patient with a history of TSC presents with irregular genital bleeding or abdominal pain. Moreover, mTOR inhibitors may be a treatment option, in addition to surgery, in cases of uterine LAM exacerbation.
- 13 December 2022
- Published by Hindawi Limited in Case Reports in Obstetrics and Gynecology
- Vol. 2022, 1-4
Open AccessA Case of Uterine Lymphangioleiomyomatosis Complicated by Tuberous Sclerosis Complex
Lymphangioleiomyomatosis (LAM) is one of the presentations of perivascular epithelioid cell neoplasm that is frequently complicated by tuberous sclerosis complex (TSC). Here, we report an uncommon case of uterine LAM treated with everolimus, which is a mechanistic target of rapamycin (mTOR) inhibitor. A 42-year-old female patient (gravida 0) with a history of TSC presented with abdominal pain. Pelvic magnetic resonance imaging showed multiple masses in the uterine myometrium, suggesting tumors that may contain internal hemorrhagic components. The lesions were suspected as the root cause of her symptoms. After everolimus was administered for a previously diagnosed renal angiolipoma, her uterine tumors temporarily decreased in size. Subsequently, laparoscopic hysterectomy and bilateral salpingectomy were performed since she could not tolerate everolimus for a long period due to the medications side effects. Furthermore, the patient was diagnosed with LAM through histopathological examination after surgical resection. Therefore, it is advisable to suspect and investigate uterine LAM when a patient with a history of TSC presents with irregular genital bleeding or abdominal pain. Moreover, mTOR inhibitors may be a treatment option, in addition to surgery, in cases of uterine LAM exacerbation.